+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Capecitabine Market - Global Forecast to 2030- Product Image
Capecitabine Market - Global Forecast to 2030- Product Image
Sale

Capecitabine Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010660
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The capecitabine market is undergoing significant transformation as oncology care shifts toward patient-centricity, digital integration, and competitive lifecycle strategies. Senior decision-makers navigating this space must address evolving patient needs, regulatory complexities, and supply chain resiliency to ensure sustainable growth.

Market Snapshot: Capecitabine Market Size and Growth Trajectory

The Capecitabine Market grew from USD 444.38 million in 2024 to USD 473.19 million in 2025, with expectations to continue expanding at a compound annual growth rate (CAGR) of 6.24% and reach USD 639.17 million by 2030.

Scope & Segmentation of the Capecitabine Market

This report provides a comprehensive analysis of the capecitabine landscape, offering in-depth segmentation, regional coverage, and a focus on technological advancements. Market coverage includes the following:

  • Indications: Breast cancer, colorectal cancer (including colon and rectal cancer), gastric cancer, and pancreatic cancer.
  • Distribution Channels: Hospital pharmacy, online pharmacy, and retail pharmacy.
  • End Users: Cancer research institutes, clinics, homecare settings, and hospitals.
  • Dosage Strengths: 150 mg and 500 mg capecitabine tablets.
  • Formulations: Standard tablet, including extended release formulations.
  • Therapy Regimens: Combination therapy and monotherapy applications.
  • Packaging: Blister packs and bottles.
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, Germany, France, Gulf countries, and several others), and Asia-Pacific (China, India, Japan, Australia, and neighboring countries).
  • Company Landscape: Major players such as Teva Pharmaceuticals, Sandoz, Viatris, Sun Pharmaceutical, Dr. Reddy's, Cipla, Hikma, Lupin, Fresenius Kabi, and Roche Registration GmbH are extensively profiled.

Key Takeaways for Senior Leaders

  • Capecitabine’s evolution from an oral 5-fluorouracil prodrug has positioned it as a mainstay in oncology, enabling flexible integration into both combination and standalone treatment protocols.
  • The market is benefiting from advances in personalized medicine and the adoption of digital health tools, enhancing the precision and monitoring of tailored regimens for diverse patient populations.
  • Generic introductions are intensifying competitive dynamics, prompting leading manufacturers to prioritize product differentiation through extended-release formulations and strategic brand lifecycle management.
  • Strategic alliances between pharmaceutical and technology companies are accelerating the integration of AI-driven analytics into dose optimization and patient selection, supporting more precise patient care.
  • Distribution channels are evolving, with rising digital prescription adoption and homecare support driving a shift in community access and delivery logistics for oral chemotherapeutics.
  • Regional diversification and localized market access strategies remain critical in adapting to heterogeneous reimbursement environments, regulatory frameworks, and procurement models globally.

Tariff Impact: United States 2025 Policy Effects

Upcoming 2025 tariff measures in the United States present cost challenges across the capecitabine supply chain. Stakeholders must navigate increased active pharmaceutical ingredient costs and potential production overheads. Manufacturers and importers are shifting sourcing strategies, while payers and providers explore reimbursement adjustments to maintain access and affordability. Patient support initiatives are expanding to offset any emerging affordability barriers due to these changes.

Methodology & Data Sources

Findings in this report are grounded in primary research through interviews with oncology experts and patients, alongside extensive review of peer-reviewed journals, regulatory filings, and clinical trial registries. Analytical frameworks incorporate SWOT and PESTEL analyses, with quantitative validation through cross-referencing of import-export records and industry data.

Why This Report Matters: Strategic Value for Decision-Makers

  • Offers an actionable framework for navigating emerging competitive, technological, and regulatory shifts within the global capecitabine market.
  • Empowers leaders to make informed investment and strategic partnership decisions by providing critical segmentation and regional insights.
  • Enhances executive preparedness for policy-driven cost shifts and digital transformation, supporting long-term resilience and differentiation.

Conclusion

This report equips decision-makers with in-depth perspectives on ongoing innovation, evolving supply chains, and best practices for optimizing capecitabine market reach. Leveraging these insights supports robust planning, improved patient outcomes, and sustainable business value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expanding use of capecitabine in combination with immune checkpoint inhibitors for metastatic colorectal cancer
5.2. Development of digital adherence monitoring tools to optimize capecitabine dosing in home-based cancer therapy
5.3. Emergence of real-world evidence studies evaluating economic impact of generic capecitabine in value-based oncology care
5.4. Investigation of capecitabine metronomic dosing schedules to reduce toxicity and improve quality of life in elderly patients
5.5. Regulatory approvals of capecitabine across emerging Asian markets driving regional market expansion and pricing competition
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Capecitabine Market, by Indication
8.1. Introduction
8.2. Breast Cancer
8.3. Colorectal Cancer
8.3.1. Colon Cancer
8.3.2. Rectal Cancer
8.4. Gastric Cancer
8.5. Pancreatic Cancer
9. Capecitabine Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy
10. Capecitabine Market, by End User
10.1. Introduction
10.2. Cancer Research Institutes
10.3. Clinics
10.4. Homecare Settings
10.5. Hospitals
11. Capecitabine Market, by Dosage Strength
11.1. Introduction
11.2. 150 Mg
11.3. 500 Mg
12. Capecitabine Market, by Formulation
12.1. Introduction
12.2. Tablet
12.2.1. Extended Release Tablet
13. Capecitabine Market, by Therapy Regimen
13.1. Introduction
13.2. Combination Therapy
13.3. Monotherapy
14. Capecitabine Market, by Packaging
14.1. Introduction
14.2. Blister Pack
14.3. Bottle
15. Americas Capecitabine Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Capecitabine Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Capecitabine Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Teva Pharmaceuticals USA, Inc.
18.3.2. Sandoz Inc.
18.3.3. Viatris Inc.
18.3.4. Sun Pharmaceutical Industries Ltd.
18.3.5. Dr. Reddy's Laboratories Limited
18.3.6. Cipla Limited
18.3.7. Hikma Pharmaceuticals PLC
18.3.8. Lupin Limited
18.3.9. Fresenius Kabi AG
18.3.10. Roche Registration GmbH
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. CAPECITABINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CAPECITABINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CAPECITABINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CAPECITABINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CAPECITABINE MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CAPECITABINE MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CAPECITABINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CAPECITABINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CAPECITABINE MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CAPECITABINE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CAPECITABINE MARKET SIZE, BY PACKAGING, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CAPECITABINE MARKET SIZE, BY PACKAGING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CAPECITABINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS CAPECITABINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CAPECITABINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES CAPECITABINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC CAPECITABINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC CAPECITABINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. CAPECITABINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. CAPECITABINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. CAPECITABINE MARKET: RESEARCHAI
FIGURE 30. CAPECITABINE MARKET: RESEARCHSTATISTICS
FIGURE 31. CAPECITABINE MARKET: RESEARCHCONTACTS
FIGURE 32. CAPECITABINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CAPECITABINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CAPECITABINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CAPECITABINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CAPECITABINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CAPECITABINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CAPECITABINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CAPECITABINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CAPECITABINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CAPECITABINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CAPECITABINE MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CAPECITABINE MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CAPECITABINE MARKET SIZE, BY COLON CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CAPECITABINE MARKET SIZE, BY COLON CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CAPECITABINE MARKET SIZE, BY RECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CAPECITABINE MARKET SIZE, BY RECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CAPECITABINE MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CAPECITABINE MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CAPECITABINE MARKET SIZE, BY PANCREATIC CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CAPECITABINE MARKET SIZE, BY PANCREATIC CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CAPECITABINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CAPECITABINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CAPECITABINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CAPECITABINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CAPECITABINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CAPECITABINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CAPECITABINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CAPECITABINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CAPECITABINE MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CAPECITABINE MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CAPECITABINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CAPECITABINE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CAPECITABINE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CAPECITABINE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CAPECITABINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CAPECITABINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CAPECITABINE MARKET SIZE, BY 150 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CAPECITABINE MARKET SIZE, BY 150 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CAPECITABINE MARKET SIZE, BY 500 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CAPECITABINE MARKET SIZE, BY 500 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CAPECITABINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CAPECITABINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CAPECITABINE MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CAPECITABINE MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CAPECITABINE MARKET SIZE, BY EXTENDED RELEASE TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CAPECITABINE MARKET SIZE, BY EXTENDED RELEASE TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CAPECITABINE MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CAPECITABINE MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CAPECITABINE MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CAPECITABINE MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CAPECITABINE MARKET SIZE, BY MONOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CAPECITABINE MARKET SIZE, BY MONOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CAPECITABINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CAPECITABINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CAPECITABINE MARKET SIZE, BY BLISTER PACK, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CAPECITABINE MARKET SIZE, BY BLISTER PACK, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CAPECITABINE MARKET SIZE, BY BOTTLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CAPECITABINE MARKET SIZE, BY BOTTLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS CAPECITABINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS CAPECITABINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS CAPECITABINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS CAPECITABINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS CAPECITABINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS CAPECITABINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS CAPECITABINE MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS CAPECITABINE MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS CAPECITABINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS CAPECITABINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS CAPECITABINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS CAPECITABINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES CAPECITABINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES CAPECITABINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES CAPECITABINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES CAPECITABINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES CAPECITABINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES CAPECITABINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES CAPECITABINE MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES CAPECITABINE MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES CAPECITABINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES CAPECITABINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES CAPECITABINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES CAPECITABINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 109. CANADA CAPECITABINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 110. CANADA CAPECITABINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 111. CANADA CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 112. CANADA CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 113. CANADA CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. CANADA CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. CANADA CAPECITABINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. CANADA CAPECITABINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. CANADA CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 118. CANADA CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 119. CANADA CAPECITABINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA CAPECITABINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA CAPECITABINE MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 122. CANADA CAPECITABINE MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 123. CANADA CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 124. CANADA CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 125. CANADA CAPECITABINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 126. CANADA CAPECITABINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 127. MEXICO CAPECITABINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 128. MEXICO CAPECITABINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 129. MEXICO CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 130. MEXICO CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 131. MEXICO CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. MEXICO CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. MEXICO CAPECITABINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. MEXICO CAPECITABINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. MEXICO CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 136. MEXICO CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 137. MEXICO CAPECITABINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 138. MEXICO CAPECITABINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 139. MEXICO CAPECITABINE MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 140. MEXICO CAPECITABINE MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 141. MEXICO CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 142. MEXICO CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 143. MEXICO CAPECITABINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 144. MEXICO CAPECITABINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL CAPECITABINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL CAPECITABINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL CAPECITABINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL CAPECITABINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL CAPECITABINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL CAPECITABINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL CAPECITABINE MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL CAPECITABINE MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL CAPECITABINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL CAPECITABINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA CAPECITABINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA CAPECITABINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA CAPECITABINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA CAPECITABINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA CAPECITABINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA CAPECITABINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA CAPECITABINE MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA CAPECITABINE MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA CAPECITABINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA CAPECITABINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA CAPECITABINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM CAPECITABINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM CAPECITABINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM CAPECITABINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM CAPECITABINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM CAPECITABINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM CAPECITABINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM CAPECITABINE MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM CAPECITABINE MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM CAPECITABINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM CAPECITABINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 219. GERMANY CAPECITABINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 220. GERMANY CAPECITABINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 221. GERMANY CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 222. GERMANY CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 223. GERMANY CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. GERMANY CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. GERMANY CAPECITABINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. GERMANY CAPECITABINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. GERMANY CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 228. GERMANY CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 229. GERMANY CAPECITABINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 230. GERMANY CAPECITABINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 231. GERMANY CAPECITABINE MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 232. GERMANY CAPECITABINE MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 233. GERMANY CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 234. GERMANY CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 235. GERMANY CAPECITABINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 236. GERMANY CAPECITABINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 237. FRANCE CAPECITABINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 238. FRANCE CAPECITABINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 239. FRANCE CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 240. FRANCE CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 241. FRANCE CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. FRANCE CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. FRANCE CAPECITABINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. FRANCE CAPECITABINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. FRANCE CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 246. FRANCE CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 247. FRANCE CAPECITABINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 248. FRANCE CAPECITABINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 249. FRANCE CAPECITABINE MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 250. FRANCE CAPECITABINE MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 251. FRANCE CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 252. FRANCE CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 253. FRANCE CAPECITABINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 254. FRANCE CAPECITABINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA CAPECITABINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA CAPECITABINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA CAPECITABINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA CAPECITABINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA CAPECITABINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA CAPECITABINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA CAPECITABINE MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA CAPECITABINE MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA CAPECITABINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA CAPECITABINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 273. ITALY CAPECITABINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 274. ITALY CAPECITABINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 275. ITALY CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 276. ITALY CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 277. ITALY CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. ITALY CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. ITALY CAPECITABINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. ITALY CAPECITABINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. ITALY CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 282. ITALY CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 283. ITALY CAPECITABINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 284. ITALY CAPECITABINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 285. ITALY CAPECITABINE MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 286. ITALY CAPECITABINE MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 287. ITALY CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 288. ITALY CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 289. ITALY CAPECITABINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 290. ITALY CAPECITABINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 291. SPAIN CAPECITABINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 292. SPAIN CAPECITABINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 293. SPAIN CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 294. SPAIN CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 295. SPAIN CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. SPAIN CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. SPAIN CAPECITABINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. SPAIN CAPECITABINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. SPAIN CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 300. SPAIN CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 301. SPAIN CAPECITABINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 302. SPAIN CAPECITABINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 303. SPAIN CAPECITABINE MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 304. SPAIN CAPECITABINE MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 305. SPAIN CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 306. SPAIN CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 307. SPAIN CAPECITABINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 308. SPAIN CAPECITABINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES CAPECITABINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES CAPECITABINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES CAPECITABINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES CAPECITABINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES CAPECITABINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES CAPECITABINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES CAPECITABINE MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES CAPECITABINE MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES CAPECITABINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES CAPECITABINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA CAPECITABINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 328. SAUDI ARABIA CAPECITABINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 330. SAUDI ARABIA CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. SAUDI ARABIA CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. SAUDI ARABIA CAPECITABINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. SAUDI ARABIA CAPECITABINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. SAUDI ARABIA CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 336. SAUDI ARABIA CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 337. SAUDI ARABIA CAPECITABINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 338. SAUDI ARABIA CAPECITABINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 339. SAUDI ARABIA CAPECITABINE MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 340. SAUDI ARABIA CAPECITABINE MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 341. SAUDI ARABIA CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 342. SAUDI ARABIA CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 343. SAUDI ARABIA CAPECITABINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 344. SAUDI ARABIA CAPECITABINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 345. SOUTH AFRICA CAPECITABINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 346. SOUTH AFRICA CAPECITABINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 347. SOUTH AFRICA CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 348. SOUTH AFRICA CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 349. SOUTH AFRICA CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 350. SOUTH AFRICA CAPECITABINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 351. SOUTH AFRICA CAPECITABINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 352. SOUTH AFRICA CAPECITABINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 353. SOUTH AFRICA CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 354. SOUTH AFRICA CAPECITABINE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 355. SOUTH AFRICA CAPECITABINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 356. SOUTH AFRICA CAPECITABINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 357. SOUTH AFRICA CAPECITABINE MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 358. SOUTH AFRICA CAPECITABINE MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 359. SOUTH AFRICA CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2018-2024 (USD MILLION)
TABLE 360. SOUTH AFRICA CAPECITABINE MARKET SIZE, BY THERAPY REGIMEN, 2025-2030 (USD MILLION)
TABLE 361. SOUTH AFRICA CAPECITABINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 362. SOUTH AFRICA CAPECITABINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 363. DENMARK CAPECITABINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 364. DENMARK CAPECITABINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 365. DENMARK CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 366. DENMARK CAPECITABINE MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 367.

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Capecitabine market report include:
  • Teva Pharmaceuticals USA, Inc.
  • Sandoz Inc.
  • Viatris Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories Limited
  • Cipla Limited
  • Hikma Pharmaceuticals PLC
  • Lupin Limited
  • Fresenius Kabi AG
  • Roche Registration GmbH

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 473.19 Million
Forecasted Market Value ( USD ) by 2030 $ 639.17 Million
Compound Annual Growth Rate6.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Capecitabine Tablets Market - Global Forecast 2025-2030 - Product Image

Capecitabine Tablets Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Oral Capecitabine Market - Global Forecast 2025-2030 - Product Image

Oral Capecitabine Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Capecitabine - Global Strategic Business Report - Product Image

Capecitabine - Global Strategic Business Report

  • Report
  • 220 Pages
  • Global
From
Capecitabine Market Report 2025 - Product Image

Capecitabine Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Capecitabine Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034 - Product Image

Capecitabine Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034

  • Report
  • 150 Pages
  • Global
From

About the Capecitabine Market

Capecitabine is a chemotherapy drug used to treat non-small cell lung cancer (NSCLC). It is a type of oral chemotherapy, meaning it is taken in pill form. Capecitabine works by blocking the growth of cancer cells and preventing them from dividing and spreading. It is often used in combination with other chemotherapy drugs to increase the effectiveness of treatment. Capecitabine is generally well-tolerated, with fewer side effects than other chemotherapy drugs. Capecitabine is a relatively new drug, first approved by the FDA in 1998. It is now widely used in the treatment of NSCLC, and is often prescribed in combination with other chemotherapy drugs. It is also used to treat other types of cancer, such as breast cancer and colorectal cancer. In the Capecitabine market, some of the major players include Roche, Pfizer, Merck, AstraZeneca, and Bristol-Myers Squibb. These companies manufacture and distribute the drug, as well as provide support services to healthcare providers and patients. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.